Zdrowie i gospodarka · 19/12/2017

FDA Releases Draft Guidance on Standards Development and Regulatory Submissions

The Food and Drug Administration (FDA) has released a draft guidance document that encourages the use of standards in regulatory submissions for products regulated by the Center for Biologics Evaluation and Research (CBER). The guidance aims to facilitate the evaluation of these products by recognizing the value of standards in their development and review process.